CDH1 and neoplasm: As shown in Table 5 and Table 6, there was no significant relationship between the expression of E-cadherin and clinical variables, including sex, age, tumor location, tumor size, lymph node, metastasis, clinical stage, pathological grade, recurrence and mortality.